Om P Singh Selected Research

Malaria

1/2021	Genetic diversity in two leading Plasmodium vivax malaria vaccine candidates AMA1 and MSP119 at three sites in India.
1/2021	Intragenomic sequence variations in the second internal transcribed spacer (ITS2) ribosomal DNA of the malaria vector Anopheles stephensi.
12/2019	Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.
1/2018	Role of IL-1β, IL-6 and TNF-α cytokines and TNF-α promoter variability in Plasmodium vivax infection during pregnancy in endemic population of Jharkhand, India.
1/2018	iNOS polymorphism modulates iNOS/NO expression via impaired antioxidant and ROS content in P. vivax and P. falciparum infection.
1/2017	Evaluation of SYBR green I based visual loop-mediated isothermal amplification (LAMP) assay for genus and species-specific diagnosis of malaria in P. vivax and P. falciparum endemic regions.
1/2016	Disagreement in genotyping results of drug resistance alleles of the Plasmodium falciparum dihydrofolate reductase (Pfdhfr) gene by allele-specific PCR (ASPCR) assays and Sanger sequencing.
12/2015	Malaria transmission in Tripura: Disease distribution & determinants.
10/2013	Microsatellite analysis of chloroquine resistance associated alleles and neutral loci reveal genetic structure of Indian Plasmodium falciparum.
1/2013	Population cytogenetic and molecular evidence for existence of a new species in Anopheles fluviatilis complex (Diptera: Culicidae).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Om P Singh Research Topics

Disease

14	Malaria 01/2021 - 07/2009
3	Infections 06/2020 - 01/2016
2	Vivax Malaria 01/2021 - 12/2019
1	Dengue (Dengue Fever) 01/2020
1	Psychomotor Agitation (Akathisia) 04/2014
1	Schizophrenia (Dementia Praecox) 04/2014
1	Dystonia (Limb Dystonia) 04/2014
1	Parkinsonian Disorders (Parkinsonism) 04/2014

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2016 - 10/2013
4	Antimalarials (Antimalarial Agents)IBA 01/2016 - 03/2012
3	VaccinesIBA 01/2021 - 12/2019
2	AntigensIBA 01/2021 - 12/2019
2	InsecticidesIBA 12/2015 - 07/2009
2	DDTIBA 12/2015 - 07/2009
1	Ribosomal DNA (rDNA)IBA 01/2021
1	lachesineIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	AntioxidantsIBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	CytokinesIBA 01/2018
1	Oxidants (Oxidizing Agents)IBA 01/2018
1	SYBR Green IIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Antipsychotic Agents (Antipsychotics)IBA 04/2014
1	Amisulpride (Solian)IBA 04/2014
1	Chloroquine (Aralen)FDA LinkGeneric 10/2013
1	Biological ProductsIBA 01/2013
1	Voltage-Gated Sodium ChannelsIBA 03/2011
1	Pyrethrins (Pyrethroids)FDA Link 07/2009